CINECA IRIS Institutional Research Information System

GIORGI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.105
AS - Asia 5.207
EU - Europa 4.376
SA - Sud America 532
AF - Africa 199
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 19.439
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.790
CN - Cina 1.709
IT - Italia 1.502
SG - Singapore 1.407
SE - Svezia 732
HK - Hong Kong 653
DE - Germania 573
BR - Brasile 475
VN - Vietnam 463
BG - Bulgaria 338
KR - Corea 320
GB - Regno Unito 295
CA - Canada 262
TR - Turchia 262
UA - Ucraina 194
FI - Finlandia 170
RU - Federazione Russa 161
IN - India 123
FR - Francia 99
CH - Svizzera 93
CI - Costa d'Avorio 77
GR - Grecia 56
JP - Giappone 50
BD - Bangladesh 44
AT - Austria 42
NG - Nigeria 38
BE - Belgio 31
IQ - Iraq 28
MX - Messico 28
IR - Iran 23
SN - Senegal 22
PL - Polonia 21
NL - Olanda 19
PK - Pakistan 19
ZA - Sudafrica 19
SA - Arabia Saudita 17
AR - Argentina 15
ID - Indonesia 14
MA - Marocco 12
UZ - Uzbekistan 12
VE - Venezuela 12
EC - Ecuador 10
ES - Italia 10
EU - Europa 9
AU - Australia 8
IE - Irlanda 7
KZ - Kazakistan 7
KE - Kenya 6
KG - Kirghizistan 6
LT - Lituania 6
NP - Nepal 6
TW - Taiwan 6
BJ - Benin 5
EG - Egitto 5
JO - Giordania 5
PH - Filippine 5
CL - Cile 4
CO - Colombia 4
CR - Costa Rica 4
DK - Danimarca 4
DZ - Algeria 4
JM - Giamaica 4
YE - Yemen 4
AL - Albania 3
BB - Barbados 3
BO - Bolivia 3
CG - Congo 3
EE - Estonia 3
ET - Etiopia 3
HU - Ungheria 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
IS - Islanda 2
KN - Saint Kitts e Nevis 2
LC - Santa Lucia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CD - Congo 1
FJ - Figi 1
GE - Georgia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
Totale 19.424
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.171
Ann Arbor 1.007
Singapore 775
Houston 767
Ashburn 763
Milan 757
Chandler 700
Hong Kong 646
Santa Clara 557
Hefei 434
Fairfield 426
Dong Ket 391
Beijing 348
Sofia 338
Dallas 308
Seoul 291
Jacksonville 239
Shanghai 229
Ottawa 205
Wilmington 202
Seattle 173
Cambridge 171
Izmir 171
New York 166
Chicago 162
Boardman 133
Los Angeles 132
Princeton 127
Lawrence 117
Medford 110
Nanjing 109
Bern 93
Abidjan 77
Des Moines 66
Jüchen 63
London 61
Alessandria 56
Rome 55
Serra 55
Dearborn 53
The Dalles 52
Buffalo 51
Florence 51
Columbus 49
Istanbul 46
Munich 42
Boulder 40
Bremen 40
Tokyo 40
Nanchang 38
Council Bluffs 37
Lagos 37
Vienna 36
Redondo Beach 35
Redwood City 33
Lancaster 32
Marseille 32
Ogden 32
São Paulo 32
Brussels 30
Hyderabad 29
Kocaeli 29
Sacile 29
Frankfurt am Main 27
Helsinki 27
Kunming 27
North York 26
Paris 26
San Diego 26
Shenyang 26
Düsseldorf 24
Fuzhou 23
Dakar 22
Pune 22
Guangzhou 21
Hebei 19
Grafing 18
Rio de Janeiro 18
Jiaxing 17
Tianjin 17
San Jose 16
Verona 15
Baghdad 14
Belo Horizonte 14
Changsha 14
Falls Church 14
Hangzhou 14
Ho Chi Minh City 14
Dhaka 13
Warsaw 13
Nürnberg 12
Tabriz 12
Turku 12
Brasília 11
Jakarta 11
Norwalk 11
Johannesburg 10
Tashkent 10
Berlin 9
Brooklyn 9
Totale 14.210
Salva come PNG Salva come JPEG
Nome #
1,2,3-Triazol-carboxanilides and 1,2,3-triazol-(N-benzyl)-carboxamides as BK-potassium channel activators. XII 374
1,2,3-Triazolo[1,5-a][1,3]benzodiazepine a new heterocyclic system: Synthesis, benzodiazepine receptor binding and theoretical calculations 318
1,2,3 Triazolo[1,2-a]benzotriazoles or 2,3-Benzo-1,3a,6,6a-Tetraazapentalenes 308
1,2,3-Triazole[4,5-d]pyridazines II. New Derivatives Tested on the Adenosine Receptors 305
An 1,2,3-Triazole Derivative Bioisoster of a Potent in Vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 299
1,2,3-triazolo [4,5-d] pyridazines-V. Preparation and adenosine receptor binding of new 4-amino derivatives. 294
1,2,3-Triazolo[1,5-a][1,4]- and 1,2,3-Triazolo[1,5-a][1,5]benzodiazepine derivatives: synthesis and benzodiazepine receptor binding. 288
N(6)-1,3-diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: Synthesis and biological evaluation as allosteric modulators of A(2A) adenosine receptors 269
1,2,3-TRIAZOLO[4,5-e]-1,2,4-TRIAZOLO[3,4-c]PYRIMIDINES 266
N(6)-SUBSTITUTED 2-PHENYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR - A COMPARISON WITH 2-N-BUTYL ANALOGOUS DERIVATIVES .5. 265
1,2,3-TRIAZOLE[4,5-D]PYRIDAZINES .3. SYNTHESIS OF NEW 4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARD ADENOSINE RECEPTORS 261
1,2,3-Triazolo[4,5-d]-1,2,4-triazolo[4,3-b]pyridazines 251
1,2,3-Triazole[4,5-d]pyridazines IV. Preparation and Adenosine Receptor Binding of New 4-and /or 7-Aminoderivatives 249
1,2,3-Triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors 246
1,2,3-Triazolodiazepine I. Preparation and Benzodiazepine Receptor Binding of 1-Benzyl and 1-Phenethyl-1,2,3-Triazolo[4,5-d][1,4]diazepines 239
N(6)-SUBSTITUTED 2-N-BUTYL-9-BENZYL-8-AZAADENINES - AFFINITY FOR ADENOSINE A(1)-RECEPTOR AND A(2)-RECEPTOR .4. 235
1,2,3-triazolo[1.5-a]quinazolines: synthesis, benzodiazepine receptor binding and theoretical calculations 232
1,2,3-TRIAZOLO[4,5-D]PYRIDAZINES. PART VI. NEW 1-SUBSTITUTED-4-AMINO DERIVATIVES AND THEIR AFFINITY TOWARDS A1 AND A2 ADENOSINE RECEPTORS 230
N(6)-Substituted 2-n-Butyl-9-Benzyl-8-Azaadenines. Affinity for Adenosine A1 and A2 Receptors. IV 226
1,2,3-triazolo[4,5-d]pyridazines - Part VI. New 1-substituted-4-amino derivatives and their affinity towards A(1) and A(2A) adenosine receptors 226
N(6)CYCLOALKYL-2-PHENYL-3-DEAZA-8-AZAADENINES: A NEW CLASS OF A1ADENOSINE RECEPTOR LIGANDS. A COMPARISON WITH THE CORRESPONDING ADENINES AND 8-AZAADENINES 219
Synthesis of New 3-Benzyl-5-Phenyl-7-Alkylaminothiazolo[4,5-d]pyrimidine-2(3H)-Thiones.) 212
"One Pot" Synthesis of 2-Substituted 9-(2'-Hydroxy-3'-aminopropyl)-8-azahypoxanthines and 8-Azaadenines [5-Substituted 3-(2'-Hydroxy-3'-aminopropyl)-7-amino and 7-hyroxy- 3H-1,2,3-triazolo[4,5-d]pyrimidines] 211
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 207
Novel 8-azapurine derivatives as ligands for A3 adenosine receptors 205
Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors 205
Adenosine A1 modulators: a patent update (2008 to present) 201
N(6)-substituted 2-phenyl-9-benzyl-8-azaadenines. Affinity for adenosine A1 and A2 receptors. A comparison with 2-N-butyl analogous derivatives.5. 200
N(9)-substituted 2-phenyl-N(6)-benzyl-8-azaadenines: A1 adenosine receptor affinity. A comparison with the corresponding N(6)-substituted 2-phenyl-N(9)-benzyl-8-azaadenines 200
N-(9-Benzyl-2-phenyl-9H-8azapurin-6-yl)-amides: A new class of A1 adenosine receptor ligands 199
N-[9-(ortho-Fluorobenzyl)-2-Phenyl-8-Azapurin-6-yl]-Amides as Potent and Selective Ligands for A1 Adenosine Receptors. 199
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 198
N(6) or N(9) Substituted 2-Phenyl-8-Azaadenines: Affinity for A1 Adenosine Receptors. VII 192
2-Fenyl-9-benzyl-6-arylamido-8-azapurines: new potent ligands of adenosine receptors 191
Synthesis and biological activity of novel substituted benzanilides as potassium channel activators. V 190
NEW 1,2,3-TRIAZOLO[1,5-a]QUINOXALINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS. II 188
8-Azapurine nucleus: a versatile scaffold for different targets 186
A QSAR study of A1adenosine receptor antagonists by a new neural network model 182
New amido derivatives as potential BKCa potassium channel activators. XI 174
2,9-Disubstituted-N6-(arylcarbamoyl)-8-azaadenines as new selective A3 adenosine receptor antagonists: Synthesis, biochemical and molecular modelling studies 174
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 172
Xanthine Oxidase (XO). 4(5)-Aminosubstituted-5(4)-Carboxyamido-1H-1,2,3-Triazoles: a New Class of Monocyclic Triazole Inhibitors 171
In vitro Inhibitors of Prostaglandin Synthesis: (p-Thiosubstituted)-Benzyl Nitrogen Heterocycles 170
Studies on 1,2,3-Triazole Derivatives as in vitro Inhibitors of Prostaglandine Synthesis 167
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 166
1,2,3-Trizoles[4,5-d]piridazines. Analogues of Prostaglandin Synthesis Inhibitors 166
Interaction of an improved model of human A1 adenosine receptor with ligands 164
Antimicrobial properties of flavonoids. 163
3-[(2-Ethoxyphenoxy)methyl]piperidine derivatives. Synthesis and antidepressant activity 163
Xanthine Oxidase Inhibition: Effect of a Linear Carboalkoxy Substituent on C(2) of the Nucleus of 8-Azahypoxanthine 162
New 4-(Benzotriazol-1-yl)-1,2,3-triazole derivatives 161
5-(4'-SUBSTITUTED-2'-NITROANILINO)-1,2,3-TRIAZOLES AS NEW POTENTIAL POTASSIUM CHANNEL ACTIVATORS. I 161
Evaluation of the Quantitative Contribution of a Phenyl Group on C(2) of 8-Azaadenosine to the Binding with Adenosine Deaminase: a New Synthesis of 8-Azaadenosine. XI. 160
Studies on Specific Inhibition of Benzodiazepine Receptor Binding by Some C-Benzoyl-1,2,3-triazole Derivatives 160
QSAR study on purine and 2,3-dihydropurine analogues as antitubercular agents 159
QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists 158
Modification of the 1,2,3-Triazole Ring Present in an Effective in vitro Inhibitor of Prostaglandin Synthesis 156
1-(1,2,3-TRIAZOL-4-YL)-BENZIMIDAZOLONES, A NEW SERIES OF HETEROCYCLIC DERIVATIVES 156
XANTHINE-OXIDASE (XO) - RELATIVE CONFIGURATION OF COMPLEXES FORMED BY THE ENZYME, 2-N-ALKYL-HYPOXANTHINE OR 8-N-ALKYL-HYPOXANTHINE AND 2-N-ALKYL-8-AZAHYPOXANTHINES .12. 155
Synthesis of N(6)-Substituted 2-Phenyl-8-Azaadenosines. Their Affinity for Adenosine A1 and A2 Receptors: a Comparison with the Corresponding 2-Phenyl-9-Benzyl-8-Azaadenines. 155
A 3D model of human A1 adenosine receptor. An evaluation of the binding free energy with ligands 155
Structure-Activity Studies on a 1,2,3-Triazole Derivative, a Potent in vitro Inhibitor of Prostaglandin Synthesys: the Role of the Heterocyclic Ring 153
Bioisosterism, enantioselectivity and molecular modeling of new effective N6- and/or N(9)-substituted 2-phenyl adenines and 8-aza analogs: different binding modes to A1 adenosine receptors 151
Synthesis of New 2-Substituted 9-?-D-Ribofuranosyl-8-Azahypoxanthine 149
ERYTHRO AND THREO 2-HYDROXYNONYL SUBSTITUTED 2-PHENYLADENINES AND 2-PHENYL-8-AZAADENINES: LIGANDS FOR A1 ADENOSINE RECEPTORS AND ADENOSINE DEAMINASE 149
TRIAZOLYLBENZIMIDAZOLTHIONES AND DERIVATIVES OF THE NEW 1,2,3-TRIAZOLO[1,5-A][1,3,5]BENZOTRIAZEPINE HETEROCYCLE 149
An initial comparison of the content of bitter substances in Cynara Scolymus L. plants obtained from rooted of shoots and micropropagation 149
Introduction of a hydroxy function on N6 8-azaadenine substituents to improve the solubility and the effectiveness of antagonists towards A1 adenosine receptors 148
1,4- and 2,4-substituted-1,2,3-triazoles as potential potassium channel activators. VII. 148
QSAR Studies on Purine and 2,3-Dihydropurine Analogues as Antitubercular Agents 146
Synthesis of New 1,2,3-triazolo[1,2-a]benzotriazole derivatives or substituted 2,3-benzo-1,3a,6,6a-tetraazapentalenes. II” 143
Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands 142
THERAPEUTIC POTENTIAL OF A1 ADENOSINE RECEPTOR LIGANDS: A SURVEY OF RECENT PATENT LITERATURE 139
SOME STRUCTURAL CHANGES ON TRIAZOLYL-BENZOTRIAZOLES AND TRIAZOLYL-BENZIMIDAZOLONES AS POTENTIAL POTASSIUM CHANNEL ACTIVATORS. III 138
2-ALKYLOXYALKYLTHIOHYPOXANTHINES AS NEW POTENT INHIBITORS OF XANTHINE OXIDASE 138
An 1,2,3,Triazole Derivatives Bioisoster of a Potent in vitro Prostaglandin Synthesis Inhibitor: Preparation and Biological Activity 137
Synthesis and functional evaluation of Adenosine A2A receptor ligand 137
New Chiral Inhibitors of Induced Platelet Aggregation: the Enantiomeric Specificity of (R)- and (S)-Methyl and Ethyl Esters of 1-{p-[(1-Hydroxycarbonyl)-ethyloxy]-benzyl}-1H-1,2,3-triazole as a Tool for Determining their Biological Target. 136
Xanthine Oxidase (XO): Relative Configuration of Complexes Formed by the Enzyme, 2- or 8-n-Alkyl-hypoxanthines and 2-n-Alkyl-8-azahypoxanthines. XII 135
A Method for the Synthesis of Racemic and Optically Active 2-Substituted 9-(2',3'-Dihidroxypropyl)-8-Azahypoxanthines and 8-Azaadenines 134
Synthesis and ADA Inhibitory Activity of New 2-Aryl-8-Azaadenosines 131
Synthesis and Biological Evaluation of New Imidazole, Pyrimidine and Purine Derivatives and Analogs as Inhibitors of Xanthine Oxidase 131
Interactions of an improved model of the the Human A1 Adenosine Receptor with Ligands 128
Xanthine Oxidase (XO). Synthesis of 4(5)-Carbxyamido-5(4)-aminoalkanoyl)amino-1,2,3-triazoles and Their Cyclization to 8-Azahypoxanthines. Evaluation for Inhibition of XO. 127
THE NEW DEGREE IN TECHICHE ERBORISTICHE (HERBAL TECHNOLOGY) 127
Evaluation of new synthesized “adenine derivatives” molecules as cytokinin-like compounds . 127
SUBSTITUTED 1,2,3-TRIAZOLO[1,5-A]QUINAZOLINES: SYNTHESIS AND BINDING TO BENZODIAZEPINE AND ADENOSINE RECEPTORS 124
Structural modifications of benzanilide derivatives, effective potassium channel openers. X 124
Steroeselectivity as an evidence for a double insertion of Antagonists within A1 Adenosine Receptors 122
Chemistry of the Dihydrothiazine Ring Moiety of Cephalosporins. A Route to 3-Formoxymethyl-3-Cephem Derivatives 122
Heterocyclic analogs of benzanilide derivatives as potassium channel activators. IX 121
NEW 1,2,3-TRIAZOLO[4,5-E]1,2,3-TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES.II 121
NEW N6-OR N(9)-HYDROXYALKYL SUBSTITUTED 8-AZAADENINES OR ADENINES AS AFFECTIVE A1 ADENOSINE RECEPTOR LIGANDS 119
Synthesis of analogs of (±)-EHNA as potent inhibitors of ADA 118
Alimentazione e qualità della vita 118
NEW 5-SUBSTITUTED-1-(2-HYDROXYBENZOYL)-BENZOTRIAZOLES, POTASSIUM CHANNELS ACTIVATORS. IV 117
1,5-Diarylsubstituted 1,2,3-triazoles as potential potassium channels activators. VI. 116
A 3D Model of the Human A1 Adenosine Receptor. An Evaluation of the Binding Free-Energy with Ligands 114
Triazolyl-benzimidazolones and triazolyl-benzotriazoles: new potential potassium channel activators. II 112
Bioisosterism, Enantioselectivity and Molecular Modelling of New Effective Substituted 2-Phenyl Adenines and 8-AZA Analogues. Different Binding Modes to A1 Adenosine Receptors 107
Totale 17.861
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021800 0 0 0 0 0 38 54 72 54 87 46 449
2021/20221.459 16 119 20 110 259 198 15 100 87 14 91 430
2022/20231.873 254 240 118 208 217 239 30 138 304 7 101 17
2023/20242.134 319 238 365 218 313 224 29 56 25 58 44 245
2024/20254.036 46 146 41 212 429 407 286 229 355 455 528 902
2025/20262.690 481 674 518 258 407 352 0 0 0 0 0 0
Totale 19.505